European Organisation For Research & Treatment Of Cancer
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
- Conditions
- Lymphoma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2024-02-22
- Target Recruit Count
- 1649
- Registration Number
- NCT00005584
- Locations
- 🇳🇱
Sint Antonius Ziekenhuis, Nieuwegein, Netherlands
🇨🇭Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
🇳🇱Leyenburg Ziekenhuis, 's-Gravenhage, Netherlands
Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-07-24
- Target Recruit Count
- 25
- Registration Number
- NCT00027677
- Locations
- 🇧🇪
U.Z. Gasthuisberg, Leuven, Belgium
🇳🇱Daniel Den Hoed Cancer Center at Erasmus Medical Center, Rotterdam, Netherlands
🇳🇱University Hospital - Rotterdam Dijkzigt, Rotterdam, Netherlands
Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain
- Conditions
- Melanoma (Skin)Metastatic Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-09-24
- Target Recruit Count
- 23
- Registration Number
- NCT00020839
- Locations
- 🇬🇧
Addenbrooke's NHS Trust, Cambridge, England, United Kingdom
🇬🇧Royal Marsden NHS Trust, London, England, United Kingdom
🇨🇭UniversitaetsSpital, Zurich, Switzerland
Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer
- Conditions
- Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-08-05
- Target Recruit Count
- 704
- Registration Number
- NCT00003636
- Locations
- 🇬🇧
University College of London Hospitals, London, England, United Kingdom
🇨🇦Doctor H. Bliss Murphy Cancer Centre, St. Johns, Newfoundland and Labrador, Canada
🇦🇹Ludwig Boltzmann Institute for Applied Cancer Research at Kaiser Franz Josef Hospital, Vienna, Austria
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma
- Conditions
- Lymphoma
- Interventions
- Biological: bleomycin sulfateBiological: filgrastimDrug: ABVD regimenBiological: pegfilgrastimDrug: BEACOPP regimen
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2023-11-09
- Target Recruit Count
- 552
- Registration Number
- NCT00049595
- Locations
- 🇳🇱
Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands
🇧🇪Clinique Universitaire De Mont-Godinne, Yvoir, Belgium
🇦🇺Canberra Hospital, Garran, Australian Capital Territory, Australia
Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor
- Conditions
- Sarcoma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-09-24
- Target Recruit Count
- 3
- Registration Number
- NCT00014313
- Locations
- 🇬🇧
Institute of Cancer Research - UK, Sutton, England, United Kingdom
Combination Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer
- Conditions
- Lung Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-07-18
- Target Recruit Count
- 5
- Registration Number
- NCT00021112
- Locations
- 🇳🇱
Academisch Ziekenhuis Utrecht, Utrecht, Netherlands
🇧🇪Algemeen Ziekenhuis Middelheim, Antwerp, Belgium
🇳🇱University Hospital - Rotterdam Dijkzigt, Rotterdam, Netherlands
MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy
- Conditions
- Prostate Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-07-24
- Target Recruit Count
- 37
- Registration Number
- NCT00027781
- Locations
- 🇮🇱
Rabin Medical Center - Beilinson Campus, Petah-Tikva, Israel
🇫🇷Centre Jean Perrin, Clermont-Ferrand, France
🇪🇸Hospital Universitario 12 de Octubre, Madrid, Spain
Imatinib Mesylate in Treating Patients With Gliomas
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-07-24
- Target Recruit Count
- 112
- Registration Number
- NCT00039364
- Locations
- 🇫🇷
CRLCC Nantes - Atlantique, Nantes-Saint Herblain, France
🇫🇷Centre Antoine Lacassagne, Nice, France
🇫🇷Institut Gustave Roussy, Villejuif, France
ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer
- Conditions
- Breast Cancer
- Locations
- 🇬🇧
Christie Hospital N.H.S. Trust, Manchester, England, United Kingdom